Company intelligence / Profile preview

Ants Innovate

Ownership: Private
Development stage: Preclinical

Overview

Ants Innovate has developed proprietary tissue engineering and cell cultivation technologies to produce whole-cut cultivated meats with the aim of replicating real meat texture and taste while minimizing environmental impact. No clinical results are applicable as this is a food-tech company.

Modalities: Cell-based cultivated meat (cellular agriculture)
Industry: Non-Drug Biotech

Drug pipeline

2 assets

Cell Essence

Pre-clinical

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Ants Innovate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ants Innovate.

Explore the full profile